HEAD & NECK CANCER
Clinical trials for HEAD & NECK CANCER explained in plain language.
Never miss a new study
Get alerted when new HEAD & NECK CANCER trials appear
Sign up with your email to follow new studies for HEAD & NECK CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug cocktail targets tough cancers in early trial
Disease control TerminatedThis early-phase study tests a combination of two targeted drugs, palbociclib and gedatolisib, in people with advanced lung, pancreatic, head & neck, or other solid tumors that have stopped responding to standard treatments. The main goal is to find the safest dose and look for e…
Matched conditions: HEAD & NECK CANCER
Phase: PHASE1 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Jun 22, 2026 12:00 UTC
-
New drug combo offers hope for head and neck cancer patients who Can't take standard treatment
Disease control OngoingThis study tests a weekly combination of chemotherapy (carboplatin and paclitaxel) plus immunotherapy (pembrolizumab) in 31 adults with advanced head and neck cancer that has spread. It is for patients who cannot take the standard drug 5-fluorouracil. The goal is to see if this r…
Matched conditions: HEAD & NECK CANCER
Phase: PHASE2 • Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated Jun 17, 2026 12:05 UTC
-
Radiation's hidden toll: new study tracks oral health in cancer survivors
Knowledge-focused OngoingThis study follows 100 head and neck cancer patients before and after radiotherapy to see how it changes their teeth, gums, and saliva over time. Researchers measure gum attachment, pocket depth, and bleeding to understand long-term oral health effects. The goal is to help doctor…
Matched conditions: HEAD & NECK CANCER
Sponsor: Ain Shams University • Aim: Knowledge-focused
Last updated Jun 18, 2026 11:48 UTC